Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA:600380)

Market Cap	20.56B -4.8%
Revenue (ttm)	15.20B -4.4%
Net Income	1.37B -7.1%
EPS	0.75 -4.2%
Shares Out	1.83B
PE Ratio	15.01
Forward PE	14.66
Dividend	0.20 (1.77%)
Ex-Dividend Date	Jul 18, 2025

Volume	7,662,164
Average Volume	12,168,213
Open	11.30
Previous Close	11.31
Day's Range	11.20 - 11.36
52-Week Range	10.07 - 14.21
Beta	0.34
RSI	44.26
Earnings Date	Mar 31, 2026

About SHA:600380

Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and traditional Chinese medicine, including cold medicine anti-viral granules and anti-tumor medicine. It also provides diagnostic reagents and equipment, such as mycoplasma pneumo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 14,350
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600380

Financial Performance

In 2024, SHA:600380's revenue was 15.62 billion, a decrease of -6.17% compared to the previous year's 16.65 billion. Earnings were 1.39 billion, a decrease of -3.90%.